S. 484 · 110th Congress

Enhancing Drug Safety and Innovation Act of 2007

Stage: In committee
Sponsor: Michael Enzi
Introduced: 2007-02-01
Latest action: 2007-03-14 · Committee on Health, Education, Labor, and Pensions. Hearings held.

Subjects

Congress

Health

Department of Health and Human Services

Commerce

Food and Drug Administration (FDA)

Science, Technology, Communications

Government Operations and Politics

Research centers

Nonprofit organizations

Social Welfare

Congressional reporting requirements

Finance and Financial Sector

Drug approvals

Drugs

Federal advisory bodies

Pharmaceutical research

Government paperwork

Government publicity

Medical supplies

Medical technology

Technological innovations

Product development

Data banks

Product safety

Financial disclosure

Labeling

Executive reorganization

Drug industry

Drug utilization

Generic drugs

Risk

Clinical trials

Health information systems

Drug interactions

Conflict of interests

Corporations

Biomedical engineering